Day-80-assessment-report-clinical-template-guidance-rev 02 ...

Indicate if, and when the product received Orphan Drug Designation(s) related to the applied indication(s).Special consideration has to be given to orphan designated products with regard to the scope of the orphan condition in relation to the therapeutic indication claimed by the applicant (for a product to be authorised as an orphan medicinal ... ................
................